Cogent Biosciences, Inc.(NASDAQ:COGT) 
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 5.15
H 5.22
L 4.63
C 4.77
V 2,063,205
10EMA 4.77
20EMA 4.77
60EMA 4.77
120EMA 4.77
250EMA 4.77